𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Hepatic steatosis assessment with CT or MRI in patients with colorectal liver metastases after neoadjuvant chemotherapy

✍ Scribed by H.A. Marsman; A.E. van der Pool; J. Verheij; J. Padmos; F.J.W. ten Kate; R.S. Dwarkasing; T.M. van Gulik; J.N.M. Ijzermans; C. Verhoef


Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
849 KB
Volume
104
Category
Article
ISSN
0022-4790

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Purpose

Preoperative radiological assessment of hepatic steatosis is recommended in patients undergoing a liver resection, but few studies investigated the diagnostic accuracy after neoadjuvant chemotherapy. The aim of this study was to compare diagnostic accuracy of preoperative CT or MRI measurements of steatosis in patients with colorectal liver metastases after induction chemotherapy.

Methods

MRI measurements (relative signal intensity decrease; RSID), N = 36, and CT scan measurements (Hounsfield units; HU), N = 32, were compared with histological steatosis assessment. Diagnostic accuracy was determined for detecting any (>5%) or marked macrovesicular steatosis (>33%).

Results

MRI showed the highest correlation with histology (r = 0.82, P < 0.001), compared to CT measurements (r = −0.65, P < 0.001). Based on linear regression analysis, radiological cut‐off values for 5% and 33% macrovesicular steatosis, corresponded to 0.7% and 19.2% RSID in the MRI‐group, and 60.4 and 54.2 HU in the CT‐group, respectively. Sensitivity and specificity for the detection of any and marked macrovesicular steatosis using MRI was 87% and 69%, and 78% and 100%, respectively, and for CT, 83% and 64%, and 70% and 87%, respectively.

Conclusion

In patients treated with neoadjuvant chemotherapy MRI measurements of steatosis showed the highest correlation coefficient and the best diagnostic accuracy, as compared to CT measurements. J. Surg. Oncol. 2011;104:10–16. © 2011 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Assessing the optimal duration of chemot
✍ Rebekah R. White; Lawrence H. Schwartz; Jose A. Munoz; Greer Raggio; William R. 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB

## Abstract ## Background and Objectives Few studies have addressed the optimal duration of chemotherapy, particularly prior to liver resection for colorectal liver metastases (CLM). The purpose of this retrospective analysis was to evaluate time to maximal response in patients receiving systemic 

Bevacizumab improves pathologic response
✍ Dario Ribero; Huamin Wang; Matteo Donadon; Daria Zorzi; Melanie B. Thomas; Cathy 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 271 KB

## Abstract ## BACKGROUND. The current study evaluated the effect of bevacizumab added to fluoropyrimidine‐plus‐oxaliplatin (5FU/OX) chemotherapy for colorectal liver metastases (CLM) on the pathologic response and nontumorous liver histology. ## METHODS. A total of 105 consecutive patients trea